title: Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology and more.
abstract: Transcatheter Cardiovascular Therapeutics (TCT) is the largest meeting in the USA in the field of interventional and vascular medicine. Every year, the symposium showcases numerous sessions dedicated to late-breaking clinical trials, a unique educational window for evidence-based medicine to guide management of patients with atherosclerosis and structural heart disease. This year, late-breaking trials at TCT mainly focused on patent foramen ovale closure, coronary intervention, interventional pharmacology and transcatheter aortic valve implantation. In this article, for the sake of the busy reader who could not attend the meeting, we highlight a selection of the trials firstly presented in the 2012 edition of TCT.
authors: Cardiovascular Department, Ferrarotto Hospital, University of Catania, Via Citelli 6, 95124, Catania, Italy. dcapodanno@gmail.com
authors: Davide
authors: D
authors: Capodanno
authors: Piera
authors: P
authors: Capranzano
mesh_terms: D002309:Cardiology / Q000639:trends*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000188:drug therapy / Q000628:therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D054092:Foramen Ovale, Patent / Q000188:drug therapy / Q000628:therapy*; D006801:Humans
chemical_list: D005343:Fibrinolytic Agents